Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Placebo Q4W
DRUG
2 trials
Sponsors
Eli Lilly and Company
Conditions
Rheumatoid Arthritis
Phase 3
A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate
Terminated
NCT01198002
Eli Lilly and Company
Rheumatoid Arthritis
Start: 2010-12-31
End: 2014-01-31
Updated: 2018-05-08
A Study in Participants With Rheumatoid Arthritis
Terminated
NCT01202773
Eli Lilly and Company
Rheumatoid Arthritis
Start: 2011-01-31
End: 2014-01-31
Updated: 2018-05-14
Related Papers
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study
RMD Open
2015-08-01
19 citations
Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study.
2015-04-14
28 citations